Abelardo De La Espriella, a right-wing outsider endorsed by former U.S. President Donald Trump, has emerged as the apparent winner of Colombia’s recent presidential election, signaling a potential shift in the country’s approach to its longstanding drug war and its relationship with the United States. De La Espriella’s victory on Sunday comes amid a broader conservative resurgence across Latin America and represents a sharp pivot away from the policies of outgoing leftist President Gustavo Petro.
De La Espriella, a criminal defense lawyer without prior government experience, campaigned on a platform of aggressive military action against drug trafficking organizations. He has pledged to dismantle narcotics networks through forceful tactics, including aerial fumigation of coca crops—an approach abandoned in Colombia since 2015 due to health concerns and legal restrictions but favored by Trump during his administration. De La Espriella also supports expanding intelligence sharing and operational collaboration with U.S. forces, though he has ruled out any direct foreign military incursions on Colombian soil.
The new president has praised recent U.S.-led military operations against drug shipments in South American waters, which have reportedly resulted in over 200 deaths, but also sparked controversy and allegations of extrajudicial killings. De La Espriella has indicated his willingness to authorize his military to target aircraft and boats suspected of transporting drugs along Colombia’s coasts. He has expressed interest in joining a recently formed coalition between the United States and other regional governments aimed at combating drug cartels.
Observers note that De La Espriella’s rise aligns with President Trump’s efforts to deepen U.S. involvement in Latin America’s drug wars through a more kinetic, militarized approach. While his predecessor Petro prioritized crop substitution programs and resisted increased militarization—leading to strained U.S.-Colombia relations and economic sanctions—De La Espriella is expected to foster a closer partnership with Washington, reinstating Colombia’s status as a key U.S. drug control partner after it was revoked last year.
Some analysts caution, however, that De La Espriella’s emphasis on military solutions risks repeating past failures. Despite nearly two decades of substantial U.S. investment in Colombia’s security forces, cocaine production and trafficking remain at historic highs, fueled by robust global demand and increasingly sophisticated smuggling methods. Critics warn that targeting senior cartel leaders without addressing the underlying financial networks may offer only temporary disruption, while potentially exacerbating violence and human rights abuses.
The incoming administration’s policies may also alter Colombia’s extradition practices. Whereas Petro’s government was hesitant to extradite high-level traffickers, focusing on building cases domestically, De La Espriella is expected to prioritize sending indicted drug figures to the United States, aligning with Trump’s demands.
Despite his pledges to swiftly reassert state control over regions dominated by armed groups, De La Espriella has already tempered some of his campaign promises, acknowledging the complexity of reestablishing government presence in contested areas.
His victory has been welcomed by some Colombians frustrated with deteriorating security under Petro, but it has also raised concerns among human rights advocates and experts who caution that a militarized crackdown may lead to increased civilian harm without significantly reducing drug trafficking. The coming months will reveal how De La Espriella balances military assertiveness with political and social realities in Colombia’s ongoing struggle against illicit narcotics.
